Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
39.5%
% of XPH's 43 holdings also in PJP
68.0%
% of PJP's 25 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
CORCEPT THERAPEUTICS INC | 4.8% | 5.1% | 4.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% | 4.0% | 4.0% |
|
VIATRIS, INC. | 3.9% | 3.8% | 3.8% |
 |
JAZZ PHARMACEUTICALS PLC | 4.0% | 3.6% | 3.6% |
|
JOHNSON & JOHNSON | 3.3% | 5.5% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PJP
|
LONGBOARD PHARMACEUTICALS, INC. | 4.2% |
|
INTRA-CELLULAR THERAPIES INC | 3.9% |
|
AXSOME THERAPEUTICS, INC. | 3.5% |
|
CATALENT INC | 3.5% |
|
ELANCO ANIMAL HEALTH, INC. | 3.4% |
|
EDGEWISE THERAPEUTICS, INC. | 3.4% |
|
ROYALTY PHARMA PLC CLASS A | 3.3% |
|
ZOETIS INC | 3.2% |
|
TARSUS PHARMACEUTICALS, INC. | 2.8% |
|
CASSAVA SCIENCES, INC. | 2.7% |
XPH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -6.0% |
|
AMGEN INC | -5.0% |
|
ABBVIE INC | -4.9% |
|
GILEAD SCIENCES INC | -3.9% |
|
REGENERON PHARMACEUTICALS | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
BIOGEN IDEC INC | -2.7% |
|
GERON CORP | -2.7% |
|
INNOVIVA, INC. | -2.4% |
|
JOHNSON & JOHNSON | -2.2% |